|
09.20-09.50 |
Opening ceremony |
|
09.50-10.20 |
Opening presentation: Opportunities and challenges of reserve research |
Chair: Enrico Premi, University of Brescia
|
10.20-10.40 |
PET imaging in anti-amyloid treatment trials |
| 10.40-11.00 |
Brain metabolism and cognitive reserve |
|
11.00-11.20 |
The fronto-parietal control network and its’ role in reserve & resilience |
|
11.20-11.40 |
Dynamic connectivity changes in preclinical frontotemporal dementia |
|
11.40-12.00 |
Protective effects of CSF sTREM2 on cognitive performance |
|
12.00-13.30 |
Lunch break |
|
12.00-13.30 |
Press conference |
Chair: Jochen Herms, LMU Munich
|
13.30-13.50 |
Cortisol and cognitive function in healthy older adults |
|
13.50-14.10 |
BACE1 inhibition and dendritic spines |
|
14.10-14.30 |
Aβ deposition and microglial response in Alzheimer’s mouse models |
|
14.30-14.50 |
Folding mechanisms of alpha-synuclein in vivo |
|
14.50-15.10 |
BACE1 in neurobiology and Alzheimer’s disease |
|
15.10-16.10 |
Coffee break and poster session |
Chair: Robert Perneczky, LMU Munich
|
16.10-16.20 |
Cerebrospinal fluid biomarkers and cognitive reserve |
|
16.20-16.30 |
Physiological effectiveness of different transcranial stimulation methods (tDCS vs tRNS) in relation to duration of stimulation |
|
16.30-16.40 |
Motor reserve moderates the detrimental effect of dopamine transporter loss on motor function in Parkinson’s disease |
|
16.40-16.50 |
Markers of vitamin B12 status in relation to CSF biomarkers and cognitive performance |
|
16.50-17.00 |
Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology |
|
17.00-17.10 |
Increased Neuroanatomic Risk for Alzheimer’s Disease Associated with Fine Particle Exposure: Exploring the Role of Cognitive Reserve |
|
17.10-17.20 |
The relationship between tau pathology and microglial activation in PSP-Richardson’s syndrome |
Chair: Michael Ewers, LMU Munich
|
17.20-17.35 |
Pro: Appropriate animal models are available |
|
17.35-17.50 |
Con: Better animal models must be developed |
|
17.50-18.00 |
Discussion and rebuttals |
|
19.30-22.00 |
Speakers’ dinner |
|
08.30-08.35 |
Welcome |
Chair: Hans-Jürgen Möller, LMU Munich
|
08.35-08.55 |
Clinical aspects of neuroinflammation in Alzheimer’s disease |
|
08.55-09.15 |
In vivo imaging of glial activation |
|
09.15-09.35 |
Neuroinflammation in Alzheimer’s disease: the ActiGliA study |
|
09.35-09.55 |
Astroglial imaging in early Alzheimer’s disease |
|
09.55-10.15 |
Inflammasome signalling in neurodegenerative disorders |
|
10.15-11.00 |
Special lecture: Microbes and dementia risk |
|
11.00-11.25 |
Coffee break |
Chair: Cecilia Samieri, University of Bordeaux
|
11.25-11.45 |
The contribution of mid-life activities to late-life cognitive reserve |
|
11.45-12.05 |
Modulation of genetic risk by lifestyle factors |
|
12.05-12.25 |
Cardiovascular health and dementia risk |
|
12.25-12.45 |
Physical activity, apolipoprotein-ɛ4 and multi-domain cognition among healthy older adults |
|
12.45-13.05 |
Sleep disturbance and dementia risk |
|
13.05-14.00 |
Lunch break |
Chair: Alina Solomon, University of Eastern Finland
|
14.00-14.20 |
Biomarkers and response to a multi-modal lifestyle intervention: The FINGER study |
|
14.20-14.40 |
Challenging neural plasticity in schizophrenia |
|
14.40-15.00 |
The metabolic brain signature of cognitive resilience |
|
15.00-15.20 |
Effects of a 3-Year Multi-Domain Intervention on cognitive performance in older adults with increased dementia risk |
|
15.20-15.40 |
Functional and structural connectivity changes and their association with lifestyle factors in the DELCODE study |
|
15.40-16.00 |
Closing words and awards presentation |
|
16.00-16.45 |
Farewell coffee |